Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.

Koshkina NV, Golunski E, Roberts LE, Gilbert BE, Knight V.

J Aerosol Med. 2004 Spring;17(1):7-14.

PMID:
15120008
2.

Cyclosporin A aerosol improves the anticancer effect of paclitaxel aerosol in mice.

Knight V, Koshkina NV, Golunski E, Roberts LE, Gilbert BE.

Trans Am Clin Climatol Assoc. 2004;115:395-404; discussion 404.

3.

Paclitaxel liposome aerosol treatment induces inhibition of pulmonary metastases in murine renal carcinoma model.

Koshkina NV, Waldrep JC, Roberts LE, Golunski E, Melton S, Knight V.

Clin Cancer Res. 2001 Oct;7(10):3258-62.

4.

Improved respiratory delivery of the anticancer drugs, camptothecin and paclitaxel, with 5% CO2-enriched air: pharmacokinetic studies.

Koshkina NV, Knight V, Gilbert BE, Golunski E, Roberts L, Waldrep JC.

Cancer Chemother Pharmacol. 2001 May;47(5):451-6.

PMID:
11391862
5.

Proapoptotic lipid nanovesicles: synergism with paclitaxel in human lung adenocarcinoma A549 cells.

Joshi N, Shanmugam T, Kaviratna A, Banerjee R.

J Control Release. 2011 Dec 20;156(3):413-20. doi: 10.1016/j.jconrel.2011.07.025. Epub 2011 Jul 23.

PMID:
21807043
6.

9-Nitrocamptothecin liposome aerosol treatment of melanoma and osteosarcoma lung metastases in mice.

Koshkina NV, Kleinerman ES, Waidrep C, Jia SF, Worth LL, Gilbert BE, Knight V.

Clin Cancer Res. 2000 Jul;6(7):2876-80.

7.

A novel approach to overcome multidrug resistance: utilization of P-gp mediated efflux of paclitaxel to attack neighboring vascular endothelial cells in tumors.

Yoshizawa Y, Ogawara K, Kimura T, Higaki K.

Eur J Pharm Sci. 2014 Oct 1;62:274-80. doi: 10.1016/j.ejps.2014.06.009. Epub 2014 Jun 20.

PMID:
24956463
8.

PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.

Yoshizawa Y, Kono Y, Ogawara K, Kimura T, Higaki K.

Int J Pharm. 2011 Jun 30;412(1-2):132-41. doi: 10.1016/j.ijpharm.2011.04.008. Epub 2011 Apr 12.

PMID:
21507344
9.

Improving anti-tumor activity with polymeric micelles entrapping paclitaxel in pulmonary carcinoma.

Gong C, Xie Y, Wu Q, Wang Y, Deng S, Xiong D, Liu L, Xiang M, Qian Z, Wei Y.

Nanoscale. 2012 Sep 28;4(19):6004-17. doi: 10.1039/c2nr31517c. Epub 2012 Aug 22.

PMID:
22910790
10.

Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.

Zhang W, Shi Y, Chen Y, Yu S, Hao J, Luo J, Sha X, Fang X.

Eur J Pharm Biopharm. 2010 Aug;75(3):341-53. doi: 10.1016/j.ejpb.2010.04.017. Epub 2010 May 6.

PMID:
20451605
11.

Aerosol delivery of liposomal formulated paclitaxel and vitamin E analog reduces murine mammary tumor burden and metastases.

Latimer P, Menchaca M, Snyder RM, Yu W, Gilbert BE, Sanders BG, Kline K.

Exp Biol Med (Maywood). 2009 Oct;234(10):1244-52. doi: 10.3181/0901-RM-8. Epub 2009 Aug 5.

PMID:
19657067
12.

Characterization and administration of cyclosporine liposomes as a small-particle aerosol.

Gilbert BE, Wilson SZ, Garcon NM, Wyde PR, Knight V.

Transplantation. 1993 Oct;56(4):974-7.

PMID:
8212222
13.

Enhanced combination therapy effect on paclitaxel-resistant carcinoma by chloroquine co-delivery via liposomes.

Gao M, Xu Y, Qiu L.

Int J Nanomedicine. 2015 Oct 22;10:6615-32. doi: 10.2147/IJN.S91463. eCollection 2015.

14.

The enhanced longevity and liver targetability of Paclitaxel by hybrid liposomes encapsulating Paclitaxel-conjugated gold nanoparticles.

Bao QY, Zhang N, Geng DD, Xue JW, Merritt M, Zhang C, Ding Y.

Int J Pharm. 2014 Dec 30;477(1-2):408-15. doi: 10.1016/j.ijpharm.2014.10.040. Epub 2014 Oct 18.

PMID:
25455782
15.

Paclitaxel (taxol) and taxoid derivates for lung cancer treatment: potential for aerosol delivery.

Gautam A, Koshkina N.

Curr Cancer Drug Targets. 2003 Aug;3(4):287-96. Review.

PMID:
12871059
16.
17.

Oral delivery of paclitaxel nanocrystal (PNC) with a dual Pgp-CYP3A4 inhibitor: preparation, characterization and antitumor activity.

Patel K, Patil A, Mehta M, Gota V, Vavia P.

Int J Pharm. 2014 Sep 10;472(1-2):214-23. doi: 10.1016/j.ijpharm.2014.06.031. Epub 2014 Jun 20.

PMID:
24954663
18.

Nanoparticle-mediated drug delivery to tumor neovasculature to combat P-gp expressing multidrug resistant cancer.

Bai F, Wang C, Lu Q, Zhao M, Ban FQ, Yu DH, Guan YY, Luan X, Liu YR, Chen HZ, Fang C.

Biomaterials. 2013 Aug;34(26):6163-74. doi: 10.1016/j.biomaterials.2013.04.062. Epub 2013 May 24.

PMID:
23706689
19.

The effect of different doses of cyclosporin A on the systemic exposure of orally administered paclitaxel.

Malingré MM, Beijnen JH, Rosing H, Koopman FJ, van Tellingen O, Duchin K, ten Bokkel Huinink WW, Swart M, Lieverst J, Schellens JH.

Anticancer Drugs. 2001 Apr;12(4):351-8.

PMID:
11335792
20.

Pharmacokinetics and tissue distribution of PGG-paclitaxel, a novel macromolecular formulation of paclitaxel, in nu/nu mice bearing NCI-460 lung cancer xenografts.

Wang X, Zhao G, Van S, Jiang N, Yu L, Vera D, Howell SB.

Cancer Chemother Pharmacol. 2010 Feb;65(3):515-26. doi: 10.1007/s00280-009-1058-x. Epub 2009 Jul 11.

Supplemental Content

Support Center